FDA.reportPublic FDA data

navepegritide 5.5 MG Injection [Yuviwel]

RxCUI
2739537
RxNorm name
navepegritide 5.5 MG Injection [Yuviwel]
Display name
navepegritide 5.5 MG Injection [Yuviwel]
Full name
navepegritide 5.5 MG Injection [Yuviwel]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:24

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
YuviwelNAVEPEGRITIDEAscendis Pharma Endocrinology, Inc.e01c1197-338f-414c-b804-808e129ebc8c2026-03-25Warnings, Adverse reactionsExact identifier
rxcui: 2739537

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
e01c1197-338f-414c-b804-808e129ebc8cyuviwel 5.5 MG Injection [PSN] · navepegritide 5.5 MG Injection [Yuviwel] [SBD] · Yuviwel 5.5 MG Injection [SY]34These highlights do not include all the information needed to use YUVIWEL safely and effectively. See full prescribing information for YUVIWEL. YUVIWEL ® (navepegritide) for injection, for subcutaneous use Initial U.S. Approval: 202620260325